Confidentiality of Interim Results in Cardiovascular (CV) Outcomes Safety Trials Part 15 Public Hearing: August 11, 2014

Question Title

* 1. Please provide your name, affiliation, and contact information.

Name:

Company:

Address:

Address 2:

City/Town:

State:

ZIP:

Country:

Email Address:

Phone Number:

Question Title

* 2. How do you plan to participate in this meeting?

I will attend in-person at the FDA White Oak Campus.

I will participate by Webcast.

Question Title

* 3. Please indicate whether you wish to address any of the issues or make a presentation.

Yes

Please submit questions/presentations to indira.hills@fda.hhs.gov

Meeting Location: FDA White Oak Campus, Building 31, The Great Room (Room 1503), White Oak Campus Conference Center 10903 New Hampshire Avenue, Silver Spring, Maryland 20993. Contact Indira Hills at indira.hills@fda.hhs.gov